
Viktor Simkovic
Examiner (ID: 3035)
| Most Active Art Unit | 2812 |
| Art Unit(s) | 2812 |
| Total Applications | 255 |
| Issued Applications | 216 |
| Pending Applications | 18 |
| Abandoned Applications | 21 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20391687
[patent_doc_number] => 20250367162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-12-04
[patent_title] => Additive for Food, Drink and Pharmaceutical Products to Improve Health and Well-Being
[patent_app_type] => utility
[patent_app_number] => 19/300296
[patent_app_country] => US
[patent_app_date] => 2025-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9594
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19300296
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/300296 | Additive for Food, Drink and Pharmaceutical Products to Improve Health and Well-Being | Aug 13, 2025 | Pending |
Array
(
[id] => 20362740
[patent_doc_number] => 20250352552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-11-20
[patent_title] => PHARMACEUTICAL COMPOSITION COMPRISING MELOXICAM
[patent_app_type] => utility
[patent_app_number] => 19/285330
[patent_app_country] => US
[patent_app_date] => 2025-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2333
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19285330
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/285330 | PHARMACEUTICAL COMPOSITION COMPRISING MELOXICAM | Jul 29, 2025 | Pending |
Array
(
[id] => 20271942
[patent_doc_number] => 12441711
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-14
[patent_title] => Compounds and their use for treatment of hemoglobinopathies
[patent_app_type] => utility
[patent_app_number] => 19/029638
[patent_app_country] => US
[patent_app_date] => 2025-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26169
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19029638
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/029638 | Compounds and their use for treatment of hemoglobinopathies | Jan 16, 2025 | Issued |
Array
(
[id] => 19961561
[patent_doc_number] => 12331045
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-17
[patent_title] => Substituted phenyl oxazolone compounds
[patent_app_type] => utility
[patent_app_number] => 18/968101
[patent_app_country] => US
[patent_app_date] => 2024-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22136
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18968101
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/968101 | Substituted phenyl oxazolone compounds | Dec 3, 2024 | Issued |
Array
(
[id] => 19798903
[patent_doc_number] => 20250064828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-27
[patent_title] => NASAL COMPOSITIONS COMPRISING ALCAFTADINE
[patent_app_type] => utility
[patent_app_number] => 18/943269
[patent_app_country] => US
[patent_app_date] => 2024-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8005
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18943269
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/943269 | NASAL COMPOSITIONS COMPRISING ALCAFTADINE | Nov 10, 2024 | Abandoned |
Array
(
[id] => 19798838
[patent_doc_number] => 20250064763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-27
[patent_title] => METHODS OF TREATMENT OF PRIMARY BILIARY CHOLANGITIS
[patent_app_type] => utility
[patent_app_number] => 18/780069
[patent_app_country] => US
[patent_app_date] => 2024-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12772
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18780069
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/780069 | METHODS OF TREATMENT OF PRIMARY BILIARY CHOLANGITIS | Jul 21, 2024 | Pending |
Array
(
[id] => 19496405
[patent_doc_number] => 20240335423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-10
[patent_title] => POLYMORPHS OF PHENYL PYRROLE AMINOGUANDIUM SALTS
[patent_app_type] => utility
[patent_app_number] => 18/676679
[patent_app_country] => US
[patent_app_date] => 2024-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55083
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18676679
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/676679 | Polymorphs of phenyl pyrrole aminoguandium salts | May 28, 2024 | Issued |
Array
(
[id] => 19571818
[patent_doc_number] => 20240376110
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => PRMT5 INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/663952
[patent_app_country] => US
[patent_app_date] => 2024-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 175274
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18663952
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/663952 | PRMT5 inhibitors and uses thereof | May 13, 2024 | Issued |
Array
(
[id] => 19479363
[patent_doc_number] => 20240327405
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-03
[patent_title] => THIOAMIDE DERIVATIVE AND PREPARATION METHOD AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/646687
[patent_app_country] => US
[patent_app_date] => 2024-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10566
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18646687
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/646687 | Thioamide derivative and preparation method and application thereof | Apr 24, 2024 | Issued |
Array
(
[id] => 19793312
[patent_doc_number] => 12234241
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-25
[patent_title] => Imidazotriazine thiobenzamide derivative, and preparation method and application thereof
[patent_app_type] => utility
[patent_app_number] => 18/634599
[patent_app_country] => US
[patent_app_date] => 2024-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7624
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18634599
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/634599 | Imidazotriazine thiobenzamide derivative, and preparation method and application thereof | Apr 11, 2024 | Issued |
Array
(
[id] => 19331207
[patent_doc_number] => 20240245637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-25
[patent_title] => MEK-INHIBITOR FOR THE TREATMENT OF VIRAL AND BACTERIAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 18/443904
[patent_app_country] => US
[patent_app_date] => 2024-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14654
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18443904
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/443904 | MEK-INHIBITOR FOR THE TREATMENT OF VIRAL AND BACTERIAL INFECTIONS | Feb 15, 2024 | Pending |
Array
(
[id] => 19172396
[patent_doc_number] => 20240158370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => CK1 alpha AND DUAL CK1 alpha / GSPT1 DEGRADING COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/462129
[patent_app_country] => US
[patent_app_date] => 2023-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 107598
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -64
[patent_words_short_claim] => 244
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18462129
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/462129 | CK1 alpha AND DUAL CK1 alpha / GSPT1 DEGRADING COMPOUNDS | Sep 5, 2023 | Pending |
Array
(
[id] => 19815039
[patent_doc_number] => 20250073246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-06
[patent_title] => METHOD OF TREATING HYPOGONADISM IN MEN
[patent_app_type] => utility
[patent_app_number] => 18/239522
[patent_app_country] => US
[patent_app_date] => 2023-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10827
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18239522
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/239522 | METHOD OF TREATING HYPOGONADISM IN MEN | Aug 28, 2023 | Pending |
Array
(
[id] => 18817426
[patent_doc_number] => 20230391766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => 1-(2-(4-CYCLOPROPYL-1H-1,2,3-TRIAZOL-1-YL)ACETYL)-4-HYDROXY-N-(BENZYL)PYRROLIDIN E-2-CARBOXAMIDE DERIVATIVES AS VHL INHIBITORS FOR THE TREATMENT OF ANEMIA AND CANCER
[patent_app_type] => utility
[patent_app_number] => 18/195134
[patent_app_country] => US
[patent_app_date] => 2023-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55267
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -70
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18195134
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/195134 | 1-(2-(4-CYCLOPROPYL-1H-1,2,3-TRIAZOL-1-YL)ACETYL)-4-HYDROXY-N-(BENZYL)PYRROLIDIN E-2-CARBOXAMIDE DERIVATIVES AS VHL INHIBITORS FOR THE TREATMENT OF ANEMIA AND CANCER | May 8, 2023 | Pending |
Array
(
[id] => 19555364
[patent_doc_number] => 20240367156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => IRON-COBALT-BASED MAGNETICALLY RECOVERABLE CATALYSTS AND METHOD OF PREPARATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/312998
[patent_app_country] => US
[patent_app_date] => 2023-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11199
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18312998
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/312998 | IRON-COBALT-BASED MAGNETICALLY RECOVERABLE CATALYSTS AND METHOD OF PREPARATION THEREOF | May 4, 2023 | Pending |
Array
(
[id] => 18808555
[patent_doc_number] => 20230382889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => COMPOUNDS FOR INHIBITING KIF18A
[patent_app_type] => utility
[patent_app_number] => 18/140533
[patent_app_country] => US
[patent_app_date] => 2023-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54897
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18140533
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/140533 | COMPOUNDS FOR INHIBITING KIF18A | Apr 26, 2023 | Pending |
Array
(
[id] => 18550644
[patent_doc_number] => 20230248644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => METHODS FOR THE TREATMENT OF PRESBYOPIA
[patent_app_type] => utility
[patent_app_number] => 18/301361
[patent_app_country] => US
[patent_app_date] => 2023-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20021
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18301361
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/301361 | METHODS FOR THE TREATMENT OF PRESBYOPIA | Apr 16, 2023 | Pending |
| 18/249228 | Compositions and Uses Thereof | Apr 13, 2023 | Pending |
Array
(
[id] => 18690911
[patent_doc_number] => 20230321075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => LYSYL OXIDASE INHIBITORS FOR TREATING MYELOID MALIGNANCIES
[patent_app_type] => utility
[patent_app_number] => 18/131183
[patent_app_country] => US
[patent_app_date] => 2023-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15333
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18131183
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/131183 | Lysyl oxidase inhibitors for treating myeloid malignancies | Apr 4, 2023 | Issued |
Array
(
[id] => 19127147
[patent_doc_number] => 20240132500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => METHOD OF TREATMENT USING SUBSTITUTED PYRAZOLO[1,5-A] PYRIMIDINE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/191283
[patent_app_country] => US
[patent_app_date] => 2023-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20120
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 506
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18191283
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/191283 | METHOD OF TREATMENT USING SUBSTITUTED PYRAZOLO[1,5-A] PYRIMIDINE COMPOUNDS | Mar 27, 2023 | Pending |